Barely Significant
← all excerpts

The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.

Neurotherapeutics · 2021 · PMC8116370 · PMID 33258073

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)
8(L) ; Eu Veh vs Ts2 Veh: + 1.9 pg/mL), while the treatment with TMG showed a trend of decrease in both Eu (Fig. 8(L) ; p = 0.06, Eu Veh vs Eu TMG: − 8.2 pg/mL) and Ts2 animals (Fig. 8(L) ; p = 0.07, Ts2 Veh vs Ts2 TMG: − 7.6 pg/mL) suggesting the potential efficacy of the compound.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.